Results 21 to 30 of about 13,801 (245)

Poxviruses Bearing DNA Polymerase Mutations Show Complex Patterns of Cross-Resistance

Biomedicines, 2022
Despite the eradication of smallpox four decades ago, poxviruses continue to be a threat to humans and animals. The arsenal of anti-poxvirus agents is very limited and understanding mechanisms of resistance to agents targeting viral DNA polymerases is ...
Graciela Andrei, Pierre Fiten, Marcela Krečmerová, Ghislain Opdenakker, Dimitrios Topalis, Robert Snoeck   +5 more
doaj   +1 more source

Battle won, war ongoing: A call for mpox vaccination in high-risk dermatologic cases [PDF]

JAAD Case Reports
Atika Malik, MD, Monique Kumar, MD, Tien-Anh N. Tran, MD, Timmy Do, PharmD, BCPS, BCIDP, Lindsay Lim, MD, DTMH   +4 more
doaj   +2 more sources

Resistance to antiviral drugs in human viruses from the subfamily Betaherpesvirinae

Вопросы вирусологии, 2022
The review provides information on the mechanisms of the emergence of resistance to antiviral drugs in human viruses from the subfamily Betaherpesvirinae. Data on the principles of action of antiviral drugs and their characteristics are given.
Mikhail V. Demin, Dmitry S. Tikhomirov, Tatiana A. Tupoleva, Felix P. Filatov   +3 more
doaj   +1 more source

In vitro susceptibility of six isolates of equine herpesvirus 1 to acyclovir, ganciclovir, cidofovir, adefovir, PMEDAP and foscarnet [PDF]

, 2007
International ...
Croubels, Siska, De Backer, Patrick, Garré, Barbara, Nauwynck, Hans, NEYTS, J, NUGENT, J, VAN DER MEULEN, K   +6 more
core   +3 more sources

Surveillance for feline herpesvirus type 1 mutation and development of resistance in cats treated with antiviral medications

Frontiers in Veterinary Science, 2023
Feline herpesvirus type 1 (FHV-1) commonly causes ocular surface disease in cats and is treated with antiviral medications targeting viral DNA polymerase (UL30/42).
Andrew C. Lewin, Nikole E. Ineck, Melanie A. Mironovich, Morgan E. Marino, Chin-Chi Liu, Ugochi Emelogu, Erinn P. Mills, Pilar Camacho-Luna, Renee T. Carter   +8 more
doaj   +1 more source

Variability in antifungal and antiviral use in hospitalized children [PDF]

, 2017
We analyzed antifungal and antiviral prescribing among high-risk children across freestanding children’s hospitals. Antifungal and antiviral days of therapy varied across hospitals.
Gerber, Jeffrey S, Goldman, Jennifer L, Hersh, Adam L, Kronman, Matthew P, Lee, Brian R, Newland, Jason G, Ross, Rachael K   +6 more
core   +2 more sources

Antivirals against Monkeypox (Mpox) in Humans: An Updated Narrative Review

Life, 2023
As of 29 August 2023, a total of 89,596 confirmed cases of Mpox (monkeypox) have been documented across 114 countries worldwide, with 157 reported fatalities.
Giuseppe Bruno, Giovanni Battista Buccoliero   +1 more
doaj   +1 more source

Characteristics of Acyclovir-Resistant Herpes Simplex Virus Infection in Hematological Patients. [PDF]

J Oral Pathol Med
ABSTRACT Objective Acyclovir‐resistant herpes simplex virus infections pose a significant challenge in immunosuppressed patients. This study aimed to characterize the clinical features, treatment outcomes, and mortality associated with acyclovir‐resistant herpes simplex virus infection. Materials and Methods A retrospective analysis was conducted on 18
Shehadeh R, Bar Ilan M, Dovrat S, Yerushalmi R, Tepperberg Oikawa M, Piperi E, Nikitakis NG, Yarom N.   +7 more
europepmc   +2 more sources

Cidofovir for the Treatment of Recurrent Respiratory Papillomatosis: A Review of the Literature [PDF]

, 2005
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/90089/1/phco.2005.25.7.977 ...
Abramson, Aduma, Andrei, Bishai, Blackledge, Bujia, Burgunda V. Sweet, Clarke, Crockett, De Clercq, Derkay, Doyle, Eicher, Endres, Gomez, Haglund, Ho, Johnson, Kashima, Kashima, Kramer, Leventhal, McCabe, Morgan, Mutz, Nadine Shehab, Norman D. Hogikyan, Osborne, Patel, Perkins, Phelps, Pransky, Pransky, Schnadig, Sedlacek, Shah, Shapiro, Smith, Tseng, Winnen   +39 more
core   +1 more source

Avaliação da eficácia do cidofovir na papilomatose respiratória recorrente juvenil Efficacy of cidofovir in recurrent juvenile respiratory papillomatosis

Brazilian Journal of Otorhinolaryngology, 2010
O uso do cidofovir para papilomatose respiratória recorrente juvenil (PRRJ) ainda não tem estudos caso-controle suficientes que comprovem sua eficácia em literatura. OBJETIVO: Avaliar fatores que influenciem o prognóstico da PRRJ, e observar a atuação do
Fabiana Valera, Lucas Maldonato, Jessé Lima, Daniel S Küpper, Rodrigo N Lacerda, Rui Mamede, Hilton Ricz   +6 more
doaj   +1 more source